GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

The star of the acquisition, anti-IgE antibody ozureprubart, is being tested as a prophylactic treatment for food allergies, ...

Welcome, everyone, to the JPMorgan Healthcare Conference. We are pleased to have with us the Almirall management team here with us today, Carlos Gallardo, Chairman and CEO; Karl Ziegelbauer, CFO; Jon ...

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...

A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...

Panelists discuss how new anti-amyloid therapies have shifted the treatment paradigm, requiring education and confidence ...

Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.

Explore innovative strategies for team-based care, emphasizing collaboration among diverse healthcare professionals to ...

Randomized trial shows resolution of about half of cases, on par with intranasal steroids ...

RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.

Here’s what to know about how VapoRub can provide relief, who should use caution and who should avoid it altogether.

Jess Harding has joined the growing list of Love Island alumni being refreshingly honest about their tweakments. A number of recent TikToks, shared by the star's aesthetic doctor, ...